£180 million Biomedical Catalyst: What do you need to know?

Gallery

This gallery contains 1 photo.

This week I attended a regenerative medicine event in London, organized by the Knowledge Transfer Network (KTN). Amongst some very interesting speakers, workshops and informal small group networking, there was discussion about the UK £180 million Biomedical Catalyst. What do … Continue reading

Grow your competitive advantage through Khan Academy

Gallery

This gallery contains 1 photo.

“Mighty oaks from little acorns grow” As medtech specialists we spend our time working in a tough, competitive environment. Rewards are not distributed equally – the lions share goes to the winners, and the rest to everyone else. Are there … Continue reading

The 2 most important things for medtech entrepreneurs

Gallery

This gallery contains 3 photos.

Last week I participated in the EuroMedtech 2012 conference in Grenoble, France. My take aways from the meeting came down to two vital things that every medtech entrepreneur should carry at their core. The weather was beautiful and the location … Continue reading

Macro insights for specialist investors

Gallery

This gallery contains 2 photos.

Last week I attended the MoneyWeek Investing Conference in London, called Protect and Prosper.  Insights were mostly macro-based and it’s targeted at private investors. As a specialist medtech investor, why did I go, and why is it relevant to this … Continue reading

Corporate VCs v VC firms: Are your investors aligned?

Gallery

This gallery contains 3 photos.

Corporate venture capital “is the investment of corporate funds directly in external start-up companies” (Wikipedia). As a medtech entrepreneur raising funds, you should know about them. They are an extremely valuable source of VC funding for your company. But they … Continue reading

What Every Medtech Entrepreneur Should Know About VCs

Gallery

This gallery contains 3 photos.

You’re an entrepreneur. You’re developing a new medtech application that’s going to take over the world and make life better for thousands, maybe millions of people. You’re idea is great, you’ve had some seed funding, perhaps a little money from … Continue reading

When Neopolitan Beats Vanilla: What Specialist Medtech Investors can Learn from Generalists

Gallery

This gallery contains 4 photos.

Many investors are specialists. Indeed, specialism in something is usually the way to excel at whatever is your choosing. But can it lead to challenges (e.g. tunnel vision), and is there a way to overcome the specialist’s curse? I’ve spent … Continue reading

8 Insights from Medtech Entrepreneurs at BioTrinity, UK

Gallery

This gallery contains 3 photos.

This week saw the BioTrinity conference in Newbury, UK, organised by OBN. It’s a fairly big date on the UK life sciences scene, with over 800 attendees, and impressively, a very healthy VC turn-out from London, Europe and even the … Continue reading

What’s the Hidden Value in TEVA’s Stock?

Gallery

This gallery contains 1 photo.

Last week I added Teva Pharmaceutical Industries (Symbol: TEVA) to my stock portfolio, at a price of $44.40. It’s not medtech, but it’s still within my chosen niche area of healthcare, and offers many of the traits I look for … Continue reading

6 Lessons for Medtech Entrepreneurs from Covidien’s Recent Acquisitions

Gallery

This gallery contains 3 photos.

The last 4 weeks has seen a flurry of medtech M&A activity from Covidien (NYSE: COV). Covidien has purchased 3 companies, all in allied spaces. The companies purchased are superDimension Ltd, Newport Medical Instruments, Inc. and Oridion Systems Ltd. Briefly, … Continue reading